2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards
20 May 2020 - 10:03PM
Business Wire
Precision medicine platform delivers innovative
clinical-genomic workflow that providers can leverage at the point
of care
2bPrecise™ Precision Health™ platform has been named a recipient
of Microsoft Corp.’s 2020 Health Innovation Awards, in the category
of “Reimagine Healthcare.”
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200520005085/en/
The awards recognize health organizations and their technology
solution partners for using Microsoft’s technology solutions in
innovative ways that help enable personalized care, empower care
teams, improve operational outcomes, protect health information and
ultimately reimagine healthcare. The 2020 winners are impacting the
industry by creating breakthrough solutions that empower health and
life sciences organizations, while meeting global, local and
industry-specific compliance and security standards.
A wholly owned subsidiary of Allscripts (NASDAQ: MDRX),
2bPrecise consumes genetic/genomic data from molecular labs and
clinical information from EHRs. It synthesizes these elements into
a clinical-genomic ontology and brings the resulting insights into
the provider’s workflow.
The award nomination featured the precision-medicine success
achieved by Murfreesboro Medical Clinic and SurgiCenter in
Tennessee (MMC) for its use of pharmacogenomic (PGx) test results
at the point of care. Shortly after implementing 2bPrecise, MMC
providers analyzed PGx results for a select group of patients who
were not responding as well to their psychiatric medications as
anticipated. Testing revealed a potential drug-gene interaction in
a significant number of these patients. Because PGx insights were
available within their workflow, clinicians reevaluated their care
plans and wrote new prescriptions for 87% of the patients – with
100% of these individuals then reporting marked improvement in
their condition.
Assaf Halevy, co-founder and CEO of 2bPrecise, said he and his
team are gratified by the Microsoft award. “It is especially
meaningful that we were recognized in the ‘reimagine healthcare’
category. That is precisely what we are trying to do – and we are
honored to work with innovators like MMC that display such
dedication to improving the quality of care.”
Allscripts established 2bPrecise in 2016, charging the company’s
leaders with developing a lab- and EHR-agnostic solution that would
help the industry bridge the chasm between scientific advances in
genetics and genomics, and their practical application at the point
of care.
“Precision medicine is quickly becoming the new standard of
care,” said Rick Poulton, President and CFO of Allscripts. “Genetic
and genomic information, however, represent an entirely new dataset
that needs to be integrated with the provider’s every-day workflow.
We are committed to enabling clinicians at any organization –
ambulatory or inpatient, academic or community-based – to be able
to access and use these insights in a timely manner.”
“During this both challenging and transformational time in the
healthcare industry, organizations are using technology to
profoundly impact how they deliver care, evolve business operations
and help people,” said Patty Obermaier, Microsoft Vice President of
U.S. Health and Life Sciences. “This year’s Microsoft Health
Innovation Award recipients are advancing the goals of improved
patient engagement and care coordination through their innovative
use of Microsoft devices, platforms and cloud and AI services.”
Nominations were submitted by health providers, payers,
pharmaceutical and life science organizations, and public and
private health institutions across the world for applying Microsoft
technology to create transformative and highly effective
innovations. An esteemed panel of industry experts selected this
year’s winners based on how their innovations represented a
forward-thinking development or implementation of a solution that
is delivering groundbreaking results and producing better health
outcomes for more people. Recipients will be highlighted on the
Microsoft in Health blog at www.Microsoft.com/Health
About 2bPrecise
The cloud-based 2bPrecise platform consumes genetic/genomic data
from molecular labs and clinical information from EHRs,
synthesizing them into a clinical-genomic ontology. The 2bPrecise
Genomic EHR Mentor (GEM™) brings the resulting precision medicine
insights into a physician’s EHR workflow for immediate and timely
use. With discrete test results consolidated into an invaluable
data set, provider organizations are likewise equipped to drive
efficient workflows for genomic interventions, extract population
analytics, design clinical intervention programs, build cohorts for
trial recruitment, enable participation in research studies and
more. Learn more at www.2bPreciseHealth.com.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers and consumers to make better
decisions, delivering better care for healthier populations. To
learn more, visit www.allscripts.com, Twitter, YouTube and It Takes
A Community: The Allscripts Blog.
Product or service names mentioned herein may be the trademarks
of their respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200520005085/en/
Erica Navar Account Executive Aria Marketing (for 2bPrecise)
(909) 538-9541 enavar@ariamarketing.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2024 to May 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From May 2023 to May 2024